![NEW CRP: Use of PET–CT with Gallium-68 Labelled Prostate Specific Membrane Antigen (PSMA) in the Diagnosis and Follow-up of Patients with Prostate Cancer (E13046) | IAEA NEW CRP: Use of PET–CT with Gallium-68 Labelled Prostate Specific Membrane Antigen (PSMA) in the Diagnosis and Follow-up of Patients with Prostate Cancer (E13046) | IAEA](https://www.iaea.org/sites/default/files/crp-prostate1140x640.jpg)
NEW CRP: Use of PET–CT with Gallium-68 Labelled Prostate Specific Membrane Antigen (PSMA) in the Diagnosis and Follow-up of Patients with Prostate Cancer (E13046) | IAEA
![FDA Approves First Commercially Available PSMA PET Imaging Agent for Prostate Cancer | Imaging Technology News FDA Approves First Commercially Available PSMA PET Imaging Agent for Prostate Cancer | Imaging Technology News](http://www.itnonline.com/sites/default/files/PSMA_PET.jpg)
FDA Approves First Commercially Available PSMA PET Imaging Agent for Prostate Cancer | Imaging Technology News
![The Role of PSMA PET/CT and PET/MRI in the Initial Staging of Prostate Cancer - European Urology Focus The Role of PSMA PET/CT and PET/MRI in the Initial Staging of Prostate Cancer - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/asset/3886fb6a-61c3-4cb5-accd-10b5fa39dc5c/gr1.jpg)
The Role of PSMA PET/CT and PET/MRI in the Initial Staging of Prostate Cancer - European Urology Focus
![Latest Prostate Cancer Imaging Technique Transforms Our Ability to Locate Cancer Cells Hidden with Standard Imaging Latest Prostate Cancer Imaging Technique Transforms Our Ability to Locate Cancer Cells Hidden with Standard Imaging](https://news.cuanschutz.edu/hubfs/Cancer%20Center/PSMA-PET-Hubspot%20Newsroom%20Header.png)
Latest Prostate Cancer Imaging Technique Transforms Our Ability to Locate Cancer Cells Hidden with Standard Imaging
![Frontiers | Intra-Individual Comparison of 18F-PSMA-1007 and 18F-FDG PET/CT in the Evaluation of Patients With Prostate Cancer Frontiers | Intra-Individual Comparison of 18F-PSMA-1007 and 18F-FDG PET/CT in the Evaluation of Patients With Prostate Cancer](https://www.frontiersin.org/files/Articles/585213/fonc-10-585213-HTML-r1/image_m/fonc-10-585213-g001.jpg)
Frontiers | Intra-Individual Comparison of 18F-PSMA-1007 and 18F-FDG PET/CT in the Evaluation of Patients With Prostate Cancer
![SciELO - Brasil - Impact of <sup>68</sup>GA-PSMA PET / CT on treatment of patients with recurrent / metastatic high risk prostate cancer - a multicenter study Impact of <sup>68</sup>GA-PSMA PET / CT SciELO - Brasil - Impact of <sup>68</sup>GA-PSMA PET / CT on treatment of patients with recurrent / metastatic high risk prostate cancer - a multicenter study Impact of <sup>68</sup>GA-PSMA PET / CT](https://minio.scielo.br/documentstore/1677-6119/qpZZZW5nFmHVkyXd6K7hctp/b3e13c0edc362abe0f6389f8ff2227391155302b.jpg)
SciELO - Brasil - Impact of <sup>68</sup>GA-PSMA PET / CT on treatment of patients with recurrent / metastatic high risk prostate cancer - a multicenter study Impact of <sup>68</sup>GA-PSMA PET / CT
![68 Ga-PSMA PET/CT identified solitary L5 metastasis in patient with... | Download Scientific Diagram 68 Ga-PSMA PET/CT identified solitary L5 metastasis in patient with... | Download Scientific Diagram](https://www.researchgate.net/publication/322258012/figure/fig2/AS:611053327118336@1522697874735/68-Ga-PSMA-PET-CT-identified-solitary-L5-metastasis-in-patient-with-recurrent-prostate.png)
68 Ga-PSMA PET/CT identified solitary L5 metastasis in patient with... | Download Scientific Diagram
![Role of Early PET/CT Imaging with 68Ga-PSMA in Staging and Restaging of Prostate Cancer | Scientific Reports Role of Early PET/CT Imaging with 68Ga-PSMA in Staging and Restaging of Prostate Cancer | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-59296-6/MediaObjects/41598_2020_59296_Fig1_HTML.png)
Role of Early PET/CT Imaging with 68Ga-PSMA in Staging and Restaging of Prostate Cancer | Scientific Reports
![An 18F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with 18F-JK-PSMA-7 During the First Year of Application | Journal of Nuclear Medicine An 18F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with 18F-JK-PSMA-7 During the First Year of Application | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/61/2/202/F3.large.jpg)
An 18F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with 18F-JK-PSMA-7 During the First Year of Application | Journal of Nuclear Medicine
![Prostate cancer–specific PET radiotracers: A review on the clinical utility in recurrent disease - ScienceDirect Prostate cancer–specific PET radiotracers: A review on the clinical utility in recurrent disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1879850017302060-gr1.jpg)